References
- 1. Asharya A, Santos J, Linde B, Anis K. Acute Kidney Injury in Pregnancy-Current Status. Adv Chronic Kidney Dis 2013; 20(3): 215-22.
- 2. Jim B, Garovic VD. Acute Kidney Injury. SeminNephrol 2017; 37(4): 378-85.
- 3. Jim B, Karumanchi SA. Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications. SeminNephrol 2017; 37(4): 386-97.
- 4. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nat Rev Nephrol 2014; 10(8): 466-80.
- 5. Naljayan MV, Karumanchi SA. New Developments in the Pathogenesis of Preeclampsia. Adv Chronic Kidney Dis 2013; 20(3): 265-70.
- 6. Chaiworapongsa T, Chaemsaithong P, Korzeniewski SJ, Yeo L, Romero R. Pre-eclampsia part 2: prediction, prevention and management. Nat Rev Nephrol 2014; 10(9): 531-40.
- 7. Petrović D. Preeklampsija i eklampsija: etiopatogeneza, dijagnostika i lečenje. U: Trudnoća i bubreg u kliničkojpraksi. Ed. Petrović D. Kragujevac, Interprint, Fakultetmedicinskihnauka 2016: 47-65.
- 8. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A Review. BMC Pregnancy and Childbirth 2009; 9(1): 8-23. [doi: 10.1186/1471-2393-9-8].
- 9. Simetka O, Klat J, Gumulec J, Dolezalkova E, Salounova D, Kacerovsky M. Early identification of women with HELLP syndrome who need plasma exchange after delivery. Transfus Apher Sci 2015; 52(1): 54-9.
- 10. Erkurt MA, Berktas HB, Kuku I, Kaya E, Koroglu M, Nizam I, et al. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange. Transfus Apher Sci 2015; 52(2): 194-8.
- 11. Petrović D, Tirmenštajn-Janković B, Živanović M, Petrović-Nikolić A, Nikolić A, Đurđević P, et al. Plazmafereza: osnovni principi i klinički značaj u trudnoći. Timoč Med Glas 2016; 41(1): 41-54.
- 12. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J ClinApher 2016; 31(3): 149-338.
- 13. Tran TT, Ahn J, Reau N. ACG Clinical Guideline: Liver Disease and Pregnancy. Am J Gastroenterol 2016; 11(2): 176-94.
- 14. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol 2016; 64(4): 933-45.
- 15. Licata A, Calvaruso V, Primignani M, Morisco F, Bugianesi E, Invernizzi P, et al. AISF position paper on liver disease and pregnancy. Dig Liver Dis 2015; 48(2): 120-37.
- 16. Fakhouri F, Vercel C, Fremeaux-Bacchi V. Obstretic Nephrology: AKI and Thrombotic Microangiopathies in Pregnancy. Clin J Am SocNephrol 2012; 7(12): 2100-6.
- 17. Kavanagh D, Goodship TH, Richards A. Atypical Hemolityc Uremic Syndrome. Semin Nephrol 2013; 33(6): 508-30.
- 18. NorisM, Remuzzi G. Overview of Complement Activation and Regulation. Semin Nephrol 2013; 33(6): 479-92.
- 19. Petrović D, Čanović P, Mijailović Ž, Popovska-Jovičić B, Jaćović S. Hemolitičko-uremijski sindrom: etiopatogeneza, dijagnostika i osnovni principi lečenja. Med Čas 2015; 49(2): 59-65.
- 20. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J ClinApher 2016; 31(3): 149-338.
- 21. Clark WF, Huang SHS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM. Plasmapheresis for the treatment of kidney diseases. Kidney Int 2016; 90(5): 974-84.
- 22. Andries G, Karass M, Yandrapilli S, Linder K, Liu D, Nelson J, et al. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab. ExpHematolOncol 2017; 6: 4. Doi: 10.1186/s40164-017-0064-7.
- 23. De Sousa-Amorim E, Pelicano MB, Quintana LF, Campistol JM. Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management. J Nephrol 2015; 28(5): 641-5.
- 24. Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V on behalf of the French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolyticuraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 2012; 8(11): 643-57.
- 25. Keating GM. Eculizumab: A Review of Its Use in Atypical HaemolyticUraemic Syndrome. Drugs 2013; 73(18): 2053-66.
- 26. Gately R, San A, Kurtkoti J, Parnham A. Life-threatening pregnancy-associated atypical haemoliticuraemic syndrome and its response to eculizumab. Nephrology 2017; 22(Suppl 1): 32-5.
- 27. Trestioreanu AZ, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningoccal infections. Cochrane Database Syst Rev 2013; 10: CD004785. Doi:10.1002/14651858.CD004785.pub5.
- 28. Scully M, Thomas M, Underwood M, Watson H, Langley K, Camilleri RS. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 2014; 124(2): 211-9.
- 29. Todorović Ž, Jovanović M, Todorović D, Petrović D, Đurđević P. Thrombotic thrombocytopenic purpura: etiopathogenesis, diagnostics and basic principles of treatment. Ser J ExpClin Res 2017; 18(1): 61-8.
- 30. Sayani FA, Abrams CS. How I treat refractory thrombotic thrombocytopenic purpura. Blood 2015; 125(25): 3860-7.
- 31. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117(5): 1499-506.
- 32. Petrović D. Akutno oštećenje bubrega: etiologija, dijagnostika i lečenje.Medicinska Istraživanja 2011;45(3):7-13.
- 33. Acharya A. Management of Acute Kidney Injury in Pregnancy for the Obstetrician. ObstetGynecolClin N Am 2016; 43(4): 747-65.
- 34. Machado S, Figueiredo N, Borges A, Sao Jose Pais M, Freitas L, Moura P. Acute kidney injury in pregnancy: a clinical challenge. J Nephrol 2012; 25(1): 19-30.